Back to Results

Alzex Neuropharma Inc (TRRI)

Alzex Neuropharma Inc. (OTC Markets: TRRI) is a common stock listing of a development-stage biopharmaceutical company focused on therapies for Alzheimer’s disease and other neurological disorders. The company was incorporated in 1971 and is based in Las Vegas, Nevada. It operated previously under the name Trinity Resources Inc. before adopting its current name in December 2022. As an OTC Markets-listed common equity, the security represents ownership in the company rather than a fund, debt instrument, or other listed product.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Technical Outlook FAQ

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
OTC-TRRI
—
—
—
—
—
—
Weak
—
—
—
0.0%
—
—
—
—
0.602 K
—
—
—
—
—
—
Valuation • Fair Value

Alzex Neuropharma Inc (OTC-TRRI) Fair Value by Valuation Model

Compare the primary fair value estimate for Alzex Neuropharma Inc (OTC-TRRI) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

Not available

Data is currently unavailable.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

DCF Fair Value

NM

Discounted cash flow valuation reference.

Ben Graham Formula Value

Not available

Data is currently unavailable.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

NM

Earnings power value estimate.

Comps Fair Value

NM

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use this section to compare the primary fair value estimate for Alzex Neuropharma Inc (OTC-TRRI) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Alzex Neuropharma Inc (OTC-TRRI)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

Not available

Data is currently unavailable.

Revenue Forecast

Not available

Data is currently unavailable.

EBITDA

0 K

Current operating profitability reference.

EBITDA Forecast

Not available

Data is currently unavailable.

How to read profitability and growth

This section helps investors review Alzex Neuropharma Inc (OTC-TRRI) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Alzex Neuropharma Inc (OTC-TRRI)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Weak

Financial pressure deserves closer review.

Piotroski Score

Not available

Data is currently unavailable.

Beneish M-Score

Not available

Data is currently unavailable.

Altman Z-Score

Not available

Data is currently unavailable.

FCF / Net Income

Not available

Data is currently unavailable.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Alzex Neuropharma Inc (OTC-TRRI). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Alzex Neuropharma Inc (OTC-TRRI)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

Not available

Days to Earnings

Not available

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

0.0%

Income yield reference.

Upcoming Dividend

Not available

Data is currently unavailable.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

Not available

Data is currently unavailable.

Payout Ratio

Not available

Data is currently unavailable.

How to read events and dividends

This section helps investors track time-sensitive items for Alzex Neuropharma Inc (OTC-TRRI), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Alzex Neuropharma Inc (OTC-TRRI) Stock Forecast & Technical Outlook

Review Alzex Neuropharma Inc (OTC-TRRI) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Alzex Neuropharma Inc (OTC-TRRI) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Alzex Neuropharma Inc (OTC-TRRI) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Alzex Neuropharma Inc (OTC-TRRI) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Alzex Neuropharma Inc (OTC-TRRI) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Alzex Neuropharma Inc (OTC-TRRI) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Alzex Neuropharma Inc (OTC-TRRI)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Not available

Analyst recommendation data for Alzex Neuropharma Inc (OTC-TRRI) is not currently available.

Buy 0
Hold 0
Sell 0
FAQ • Fast Investor Answers

Alzex Neuropharma Inc (OTC-TRRI) Stock FAQ

Quick answers about Alzex Neuropharma Inc (OTC-TRRI) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
Not available
Data is currently unavailable
Valuation Rating
Not available
Classification is not available
Analyst Target
Not available
Data is currently unavailable
Financial Health
Weak
Current financial-health read

A fair value estimate for Alzex Neuropharma Inc (OTC-TRRI) is not currently available in the latest data file.

A clear undervalued or overvalued classification is not currently available in the latest data file.

An analyst price target for Alzex Neuropharma Inc (OTC-TRRI) is not currently available in the latest data file.

The current financial health read for Alzex Neuropharma Inc (OTC-TRRI) is Weak. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

Based on the current data, dividend yield is 0.0%.

The current market capitalization listed for Alzex Neuropharma Inc is 0.602 K.

The ticker symbol for Alzex Neuropharma Inc is OTC-TRRI, and the stock is listed on OTC Markets.

Alzex Neuropharma Inc (OTC-TRRI) is listed on OTC Markets.

Similar Metals & Mining Stocks on OTC Markets View more

BHP Group Ltd (BHPLF) BHP Group Ltd (BHPLF)
Zijin Mining Group Co Ltd ADR (ZIJMY) Zijin Mining Group Co Ltd ADR (ZIJMY)
Zijin Mining Group Co Ltd-H (ZIJMF) Zijin Mining Group Co Ltd-H (ZIJMF)
Grupo Mexico, S.A.B. De C.V. (GMBXF) Grupo Mexico, S.A.B. De C.V. (GMBXF)
Glencore PLC (GLCNF) Glencore PLC (GLCNF)
Glencore PLC ADR (GLNCY) Glencore PLC ADR (GLNCY)
ArcelorMittal SA (AMSYF) ArcelorMittal SA (AMSYF)
Anglo American PLC ADR (NGLOY) Anglo American PLC ADR (NGLOY)
Antofagasta PLC (ANFGF) Antofagasta PLC (ANFGF)
Fortescue Metals Group Ltd (FSUMF) Fortescue Metals Group Ltd (FSUMF)
Fortescue Metals Group Ltd ADR (FSUGY) Fortescue Metals Group Ltd ADR (FSUGY)
Fresnillo PLC (FNLPF) Fresnillo PLC (FNLPF)
First Quantum Minerals Ltd (FQVLF) First Quantum Minerals Ltd (FQVLF)
Lundin Mining Corporation (LUNMF) Lundin Mining Corporation (LUNMF)
Northern Star Resources Ltd (NESRF) Northern Star Resources Ltd (NESRF)
Nippon Steel Corp ADR (NPSCY) Nippon Steel Corp ADR (NPSCY)
Industrias Penoles Sab De CV (IPOAF) Industrias Penoles Sab De CV (IPOAF)
Valterra Platinum Ltd DRC (ANGPY) Valterra Platinum Ltd DRC (ANGPY)
Norsk Hydro ASA (NHYKF) Norsk Hydro ASA (NHYKF)
Norsk Hydro ASA ADR (NHYDY) Norsk Hydro ASA ADR (NHYDY)
Evolution Mining Ltd (CAHPF) Evolution Mining Ltd (CAHPF)
Boliden AB ADR (BDNNY) Boliden AB ADR (BDNNY)
South32 ADR (SOUHY) South32 ADR (SOUHY)
Lundin Gold Inc (LUGDF) Lundin Gold Inc (LUGDF)